0.45% -0.0181

Journey Medical Corp (DERM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Journey Medical Corp Stock (DERM) Company Profile

Journey Medical Corp

Healthcare (1233)

480-434-6670

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

DERM's Discussions on Twitter

Vergleichen Sie DERM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DERM Journey Medical Corp	3.9819	81.68M	79.89M	-12.35M	32.92M	-0.83
ZTS Zoetis Inc	163.87	74.45B	9.15B	2.43B	2.31B	5.32
TAK Takeda Pharmaceutical Co Adr	13.11	41.98B	30.27B	1.93B	3.45B	0.6044
HLN Haleon Plc Adr	9.205	41.66B	14.26B	1.55B	0	0.3383
TEVA Teva Pharmaceutical Industries Ltd Adr	20.95	24.35B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	11.63	14.28B	15.05B	-883.30M	1.89B	-0.74

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-22	Eingeleitet	Rodman & Renshaw	Buy
2024-06-28	Fortgesetzt	ROTH MKM	Buy
2021-12-07	Eingeleitet	B. Riley Securities	Buy

Journey Medical Corp Aktie (DERM) Neueste Nachrichten

Finanzdaten der Journey Medical Corp-Aktie (DERM)

Journey Medical Corp (DERM)

Journey Medical Corp Stock (DERM) Company Profile

Vergleichen Sie DERM mit anderen Aktien

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Journey Medical Corp Aktie (DERM) Neueste Nachrichten

DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times

LAVA Therapeutics NV (LVTX)’S -5.56% Retreat Makes It Worth Considering Again - Stocks Register

Tillys Inc (TLYS): Major Improvements, Worth A Look - Stocks Register

Journey Medical (NASDAQ:DERM) Shares Down 5.3%Here's Why - MarketBeat

SWK Holdings Provides Portfolio Update - AccessWire

Malaysia’s education, business, healthcare AI journey in 2024 - The Malaysian Reserve

Bridgebio’s Attruby FDA nod boosts stock; 10 November approvals - BioWorld Online

One Man Shares His Journey With ATTR-CM - Health Central

Journey Medical Decline Means Insider Profits Down To US$101k - Simply Wall St

Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Position in Service Properties Trust (NASDAQ:SVC) - Defense World

Walleye Capital LLC Takes $220,000 Position in The Taiwan Fund, Inc. (NYSE:TWN) - Defense World

GE HealthCare - linkedin

Injection Perfection Medical Spa Unveils Morpheus8 OptimasMax for Comprehensive Aesthetic Treatments. - StreetInsider.com

How we help consumers eat well and support their health - Danone

Our mission - Danone

Michelle Borland of Vital Strandz: The Journey to Becoming a Trusted Hair Loss Practitioner for Individuals in the USA - Yahoo Finance

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Journe - GuruFocus.com

Palmar Hyperhidrosis Pipeline Trends 2024: Clinical Trials, - openPR

Nahdi Medical Company solidifies its position as the largest primary healthcare provider in the Kingdom - ZAWYA

Journey Medical Corp (DERM) Should Be Considered For The Next Few Weeks - Stocks Register

AI Face Reshape Simulator: How It Transforms Med Spa Consultations - Perfect Corp.

One Behavioral Provider’s Decision to Co-Develop Technology - Healthcare Innovation

Women of Influence: Erica Conroy's journey from the lab to the C-SuiteColumbus Business First - The Business Journals

FY2024 EPS Estimate for Journey Medical Decreased by Analyst - MarketBeat

Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys - Yahoo Finance

FY2024 EPS Estimates for Journey Medical Boosted by B. Riley - MarketBeat

Showcasing the Journey of Researchers and Entrepreneurs at UP Manila’s Salinlohiya 2024 - University of the Philippines Manila

NY AI medical company wins global health tech competition at Scientific Sessions 2024 - American Heart Association

Journey Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in October - MarketBeat

Despite Journey Medical's Pullback, Insiders Still Gained US$118k - Yahoo Finance

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance

Topgolf Callaway Q3 Earnings & Revenues Top Estimates, Fall Y/Y - Yahoo Finance

Entero, Journey to merge, creating oncology-focused biopharma - Investing.com

Journey Medical Corp (DERM) Q3 2024 Earnings: Revenue Hits $14.6M, EPS Loss of $0.12 Beats Estimates - GuruFocus.com

Journey Medical earnings beat by $0.05, revenue topped estimates - Investing.com

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Runway Growth Finance Corp. (RWAY) Q3 Earnings and Revenues Lag Estimates - Yahoo Finance

Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Reports Q3 Revenue $14.6M - Marketscreener.com

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance

Lost emperor penguin recovering after record journey across Southern Ocean - ABC News

Best travel insurance companies in 2024 - USA TODAY

FY2024 EPS Estimates for Journey Medical Raised by Analyst - MarketBeat

Q3 EPS Estimates for Journey Medical Reduced by Roth Capital - Defense World

FDA approves Journey Medical’s rosacea treatment Emrosi - Yahoo Finance

Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report (NASDAQ:DERM) - Seeking Alpha

US FDA approves Journey Medical's drug for long-term skin condition - Reuters

Journey Medical gains as US FDA approves skin condition drug - XM

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? - Yahoo Finance

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - Yahoo Finance

mWell says users gain access to 26 MPH hospitals - BusinessWorld Online

Finanzdaten der Journey Medical Corp-Aktie (DERM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie DERM